|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7125 | (2006.01) |
| (11) | Number of the document | 3301177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17184486.3 |
| Date of filing the European patent application | 2012-11-16 | |
| (97) | Date of publication of the European application | 2018-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (30) | Number | Date | Country code |
| 201161561710 P | 2011-11-18 | US | |
| 201261615618 P | 2012-03-26 | US | |
| 201261680098 P | 2012-08-06 | US |
| (72) |
KALLANTHOTTATHIL, Rajeev G., US
ZIMMERMANN, Tracy, US
MANOHARAN, Muthiah, US
MAIER, Martin, US
KUCHIMANCHI, Satyanarayana, US
CHARISSE, Klaus, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | RNRi agentai, kompozicijos ir jų naudojimo būdai, skirti su transtiretinu (TTR) susijusioms ligoms gydyti |
| RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-10-27 | 14 | 289.00 EUR |
| 2026-11-16 |